Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

Saved in:
Bibliographic Details
Title: Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.
Authors: Angka L; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Biochemistry Microbiology and Immunology, Ottawa, Ontario, Canada., Tennakoon G; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Biochemistry Microbiology and Immunology, Ottawa, Ontario, Canada., Cook DP; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Cellular and Molecular Medicine, Ottawa, Ontario, Canada., Martel AB; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Market M; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Biochemistry Microbiology and Immunology, Ottawa, Ontario, Canada., Tanese de Souza C; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Cummins E; adMare Bioinnovations, Vancouver, British Columbia, Canada., Samudio I; adMare Bioinnovations, Vancouver, British Columbia, Canada., Kekre N; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Ardolino M; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Biochemistry Microbiology and Immunology, Ottawa, Ontario, Canada., Vanderhyden BC; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa Department of Cellular and Molecular Medicine, Ottawa, Ontario, Canada., Kennedy MA; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Auer RC; Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada rauer@ohri.ca.; University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jan 29; Vol. 14 (1). Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-013304